Change of Advisor

22^nd Feb 2017

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as Nominated Adviser and sole Broker to the Company with immediate effect.

EKF Diagnostics Holdings plc Julian Baines, CEO Richard Evans, Finance Director and COO	00 44 29 2071 0570
N+1 Singer Alex Price / Alex Laughton-Scott	00 44 20 7496 3000
Walbrook PR Limited Paul McManus Lianne Cawthorne	00 44 20 7933 8780 or ekf@walbrookpr.com 00 44 7980 541 893 00 44 7584 391 303

Back to Listing

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

EKF at MEDLAB - Singapore 2019

EKF signs DiaSpect Tm U.S. distribution agreement with McKesson to launch McKesson Consult® Hb analyzer

FDA cleared POC hemoglobin analyzer to be sold across the USA by the market’s leading and most established healthcare distributor

4th Annual AIDF Africa Summit

Meet EKF Diagnostics at AIDF 2019 in Nairobi, Kenya this February.

MEDLAB Middle East - Feb 2019

"The world's largest lab expo" - Medlab Middle East is a leading laboratory and flagship exhibition and Conference spanning across Middle East, Asia and West Europe.

Reliable Point-of-Care lactate analysis in cattle

Measuring lactate concentrations in cattle has been shown to be incredibly useful. This article discusses new methods available to farmers and veterinarians to get fast and reliable results without leaving the animal’s side.